Expression of protein kinase C β1 confers resistance to TNFα‐ and paclitaxel‐induced apoptosis in HT‐29 colon carcinoma cells

The expression of different protein kinase C (PKC) isoenzymes has been shown to vary with proliferation rates, differentiation or apoptosis in normal colon crypts. In addition, the activity of some PKC isoenzymes appears to be reduced in colorectal cancer. The aim of the present work was to determine whether modulation of PKC expression would affect the susceptibility of a p53‐defective colon carcinoma cell line to different apoptotic treatments. HT‐29 cells exhibited sensitivity to paclitaxel (Taxol) and tumor necrosis factor α (TNFα) in a dose‐ and time‐dependent manner but were relatively resistant to etoposide. Inhibition of PKC activity augmented the susceptibility of HT‐29 cells to apoptosis, and phorbol ester induction of PKC reduced such susceptibility. Transfected HT‐29PKC cells, hyper‐expressing the β1 isoform of PKC, were less sensitive to TNFα and paclitaxel than the normal counterpart. The present data 1) indicate that the expression of PKC influences the susceptibility of HT‐29 colon cancer cells to apoptotic drugs apparently regardless of their mechanism of action, and 2) suggest paclitaxel as a potential candidate for the treatment of colon cancer, possibly in association with inhibitors of PKC (α and β) at doses not cytotoxic per se. © 2001 Wiley‐Liss, Inc.

[1]  W. Karnes,et al.  Distinct protein kinase C isozymes signal mitogenesis and apoptosis in human colon cancer cells. , 1999, Gastroenterology.

[2]  A. Larsen,et al.  The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Westwick,et al.  Cytokine-induced Apoptosis in Epithelial HT-29 Cells Is Independent of Nitric Oxide Formation , 1999, The Journal of Biological Chemistry.

[4]  P. Gibson,et al.  Activation of protein kinase C augments butyrate-induced differentiation and turnover in human colonic epithelial cells in vitro. , 1999, Carcinogenesis.

[5]  N. Petrelli,et al.  Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes. , 1998, Gastroenterology.

[6]  W. Karnes,et al.  PKC isoforms in intestinal mucosa and adenomas of APCMIN mice , 1998 .

[7]  C. Stein,et al.  Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  P. Codogno,et al.  Expression and posttranslational fate of cathepsin D in HT-29 tumor cells depend on their enterocytic differentiation state. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[9]  Y. Pommier,et al.  7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53. , 1997, Experimental cell research.

[10]  J. Lord,et al.  Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. , 1997, Molecular pathology : MP.

[11]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[12]  R. Brown,et al.  Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance. , 1996, Molecular pharmacology.

[13]  C. Tacchetti,et al.  Apoptosis of L929 cells by etoposide: a quantitative and kinetic approach. , 1996, Experimental cell research.

[14]  B. Rigas,et al.  Staurosporine inhibits the proliferation, alters the cell cycle distribution and induces apoptosis in HT-29 human colon adenocarcinoma cells. , 1996, Cancer letters.

[15]  B. Marian,et al.  Protein kinase C tissue localization in human colonic tumors suggests a role for adenoma growth control. , 1996, Gastroenterology.

[16]  P. Bergman,et al.  Partial Reversal of Multidrug Resistance in Human Breast Cancer Cells by an N-Myristoylated Protein Kinase C- Pseudosubstrate Peptide (*) , 1996, The Journal of Biological Chemistry.

[17]  S. Targan,et al.  Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. , 1995, Journal of immunology.

[18]  L. Dekker,et al.  The protein kinase C and protein kinase C related gene families. , 1995, Current opinion in structural biology.

[19]  I. Weinstein,et al.  Expression of multiple isoforms of protein kinase C in normal human colon mucosa and colon tumors and decreased levels of protein kinase C β and η mRNAs in the tumors , 1994, Molecular carcinogenesis.

[20]  K. Kohn,et al.  p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. , 1994, Cancer research.

[21]  D. Housman,et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.

[22]  R. Slebos,et al.  Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. , 1993, Cancer research.

[23]  J. Hickman,et al.  Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. , 1993, The EMBO journal.

[24]  S. Arbuck,et al.  Taxol: the first of the taxanes, an important new class of antitumor agents. , 1992, Seminars in oncology.

[25]  N. Shen,et al.  Apoptosis and DNA fragmentation precede TNF‐induced cytolysis in U937 cells , 1992, Journal of cellular biochemistry.

[26]  I. Weinstein,et al.  The modulation of growth by HMBA in PKC overproducing HT29 colon cancer cells. , 1991, Biochemical and biophysical research communications.

[27]  J. Utsunomiya,et al.  Protein kinase C activity as marker for colorectal cancer , 1991, International journal of cancer.

[28]  P. Walker,et al.  Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. , 1991, Cancer research.

[29]  I. Weinstein,et al.  Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression , 1990, Molecular and cellular biology.

[30]  M. Mattern,et al.  Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation. , 1990, Cancer research.

[31]  J. Tavernier,et al.  Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. , 1986, Journal of immunology.

[32]  L. Liu,et al.  Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. , 1984, Cancer research.

[33]  F. Schildberg,et al.  Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. , 1991, Cancer research.

[34]  F. Balkwill,et al.  DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon‐γ , 1987, European journal of immunology.